Anti-tumor potency in newly developed black garlic (extracts)
reached 50% in the 1.0 mg treatment after three injections
on day 2, 4, 6 after tumor transplantation (Sasaki et
al. 2007). The average tumor size in non-cured mice of the
black garlic-treated mice was half that of the non-treated
control group. By contrast, the fresh garlic extracts used as
a reference failed to eradicate the transplanted tumor, even
though the average tumor size in non-cured animal was less
than that of non-treated control mice. These results indicated
the presence of strong anti-tumor potency in the black
garlic (extracts).